OOIR: Observatory of International Research

Papers

(The H4-Index of JAMA Psychiatry is 76. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)

Article	Citations
Suicide Mortality and Coronavirus Disease 2019—A Perfect Storm?	616
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder	603
Establishment of Best Practices for Evidence for Prediction	395
Internet-Based Cognitive Behavioral Therapy for Depression	389
Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic	374
Addressing the COVID-19 Pandemic in Populations With Serious Mental Illness	336
Prevention of Psychosis	276
How COVID-19 Affects the Brain	274
Perturbations in Gut Microbiota Composition in Psychiatric Disorders	266
Association Between Physical Activity and Risk of Depression	253
Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence	237
Association of Psychiatric Disorders With Mortality Among Patients With COVID-19	234
Battling the Modern Behavioral Epidemic of Loneliness	218
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia	202
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	197
From Basic Science to Clinical Application of Polygenic Risk Scores	185
Psychotherapy for Depression Across Different Age Groups: A Systematic Review and Meta-analysis	161
Mental Health in the Coronavirus Disease 2019 Emergency—The Italian Response	156
Could Polygenic Risk Scores Be Useful in Psychiatry?	156
Psychosocial Interventions and Immune System Function	152
Association Between Mental Health Disorders and Mortality Among Patients With COVID-19 in 7 Countries	147
Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death	147
Associations Between Prenatal Cannabis Exposure and Childhood Outcomes	145
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder	144
Posttraumatic Stress Disorder in Patients After Severe COVID-19 Infection	142

Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic	142
Dissecting the Association Between Inflammation, Metabolic Dysregulation, and Specific Depressive Symptoms	141
Telepsychiatry and the Coronavirus Disease 2019 Pandemic—Current and Future Outcomes of the Rapid Virtualization of Psychiatric Care	141
Probability of Transition to Psychosis in Individuals at Clinical High Risk	140
Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post–COVID-19 Conditions	135
Long-term Outcomes of Cognitive Behavioral Therapy for Anxiety-Related Disorders	133
Association of OPRM1 Functional Coding Variant With Opioid Use Disorder	131
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	125
Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression	122
Dialectical Behavior Therapy for Posttraumatic Stress Disorder (DBT-PTSD) Compared With Cognitive Processing Therapy (CPT) in Complex Presentations of PTSD in Women Survivors of Childhood Abuse	118
Functional Magnetic Resonance Imaging–Guided Personalization of Transcranial Magnetic Stimulation Treatment for Depression	116
The Coronavirus Disease 2019 (COVID-19) Outbreak and Mental Health	116
Cognitive Behavioral Treatments for Anxiety in Children With Autism Spectrum Disorder	115
Immediate and Longer-Term Changes in the Mental Health and Well-being of Older Adults in England During the COVID-19 Pandemic	114
The Current Status of Psychedelics in Psychiatry	114
Virtual Histology of Cortical Thickness and Shared Neurobiology in 6 Psychiatric Disorders	114
Association of Symptoms of Depression With Cardiovascular Disease and Mortality in Low-, Middle-, and High-Income Countries	112
Adjunctive Psychotherapy for Bipolar Disorder	109
Association of Suicide Prevention Interventions With Subsequent Suicide Attempts, Linkage to Follow-up Care, and Depression Symptoms for Acute Care Settings	107
Association of Outdoor Artificial Light at Night With Mental Disorders and Sleep Patterns Among US Adolescents	105
Efficacy of Digital Cognitive Behavioral Therapy for the Treatment of Insomnia Symptoms Among Pregnant Women	101
Effect of Layperson-Delivered, Empathy-Focused Program of Telephone Calls on Loneliness, Depression, and Anxiety Among Adults During the COVID-19 Pandemic	100
Long-term Changes in Cognitive Functioning in Individuals With Psychotic Disorders	99
Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia	98
Psychosocial Stressors at Work and the Risk of Sickness Absence Due to a Diagnosed Mental Disorder	98
Effect of Zuranolone vs Placebo in Postpartum Depression	97
Transcriptomic Landscape and Functional Characterization of Induced Pluripotent Stem Cell–Derived Cerebral Organoids in Schizophrenia	97
Racial Differences in Statewide Suicide Mortality Trends in Maryland During the Coronavirus Disease 2019 (COVID-19) Pandemic	95
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	95
Male and Female Physician Suicidality	93
Coached Mobile App Platform for the Treatment of Depression and Anxiety Among Primary Care Patients	92
Opportunities From the Coronavirus Disease 2019 Pandemic for Transforming Psychiatric Care With Telehealth	92
Neurocognitive Functioning in Individuals at Clinical High Risk for Psychosis	92
Reward-Processing Behavior in Depressed Participants Relative to Healthy Volunteers	91
Association of High-Potency Cannabis Use With Mental Health and Substance Use in Adolescence	91
Prescription Opioid Use and Risk for Major Depressive Disorder and Anxiety and Stress-Related Disorders	90
Joint International Collaboration to Combat Mental Health Challenges During the Coronavirus Disease 2019 Pandemic	89
Etiology of Autism Spectrum Disorders and Autistic Traits Over Time	87
The Genetic Architecture of Depression in Individuals of East Asian Ancestry	85
Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure	85
Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses	83
Shared Genetic Loci Between Body Mass Index and Major Psychiatric Disorders	82
National Trends in Mental Health Care for US Adolescents	81
Association of Preeclampsia in Term Births With Neurodevelopmental Disorders in Offspring	81
Association of Patient Treatment Preference With Dropout and Clinical Outcomes in Adult Psychosocial Mental Health Interventions	81
Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain	81
Association of Cannabis Use During Adolescence With Neurodevelopment	79
Sequential Combination of Pharmacotherapy and Psychotherapy in Major Depressive Disorder	76
Risk of Subjection to Violence and Perpetration of Violence in Persons With Psychiatric Disorders in Sweden	76
Association of Drug Cues and Craving With Drug Use and Relapse	76

Prevention of Incident and Recurrent Major Depression in Older Adults With Insomnia